Cerebral vascular protective effect of ginkgo diterpene lactone meglumine injection.
10.19540/j.cnki.cjcmm.2017.0210
- Author:
Zhuo-Qiong LI
1
;
Ze-Yu CAO
1
;
Liang CAO
1
;
Zhi-Peng KE
1
;
Zhen-Zhong WANG
1
;
Wei XIAO
1
Author Information
1. State Key Laboratory of New-tech for Chinese Medicine Pharmaceutical Process, Jiangsu Kanion Parmaceutical Co., Ltd., Lianyungang 222001, China.
- Publication Type:Journal Article
- Keywords:
cerebral ischemia;
ginkgo diterpene lactone meglumine injection;
vascular protection
- From:
China Journal of Chinese Materia Medica
2017;42(24):4738-4743
- CountryChina
- Language:Chinese
-
Abstract:
The left middle cerebral artery occlusion (MCAO) model was made by inserting the nylon thread plug into the internal carotid artery. The behavioral score, cerebral infarction area, brain water content, ethidium bromide (EB) spillover, coagulation four indices, occludin and MMP-9 expression in brain tissues were detected after 14 days of administration, to investigate whether the protective effect of ginkgo diterpene lactone meglumine injection (GDLMI) which had obvious protective effect on cerebral ischemic injury in the previous experiment was related to reducing the permeability of the blood-brain barrier (BBB) and reducing the risk of bleeding, and to explore its possible mechanism of action. The results showed that GDLMI could effectively alleviate the behavioral changes caused by MCAO at 24 h, reduce the behavioral score, improve the edema of brain tissue, reduce the EB overflow rate, reduce the bleeding tendency caused by long-term administration, significantly reduce the occlusion deficiency in ischemic brain tissue of model rats, and down-regulate MMP-9 expression. The above results indicate that GDLMI has obvious effect on cerebral ischemia, and the therapeutic effect of GDLMI may mainly depend on lowering the permeability of blood-brain barrier to improve brain edema.
